277
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy

ORCID Icon & ORCID Icon
Pages 91-103 | Received 04 Jun 2023, Accepted 09 Sep 2023, Published online: 29 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.